CBX7 and acute myeloid leukemia: Cases in which CBX7 is strongly upregulated include gastric cancer (Zhang et al, 2010), germinal center-derived follicular lymphomas (Scott et al, 2007), and acute myeloid leukemia, where it promotes proliferation, suppresses differentiation, and contributes to the self-renewal of stem cells (Jung et al, 2019).